Controversies: Optic nerve sheath fenestration versus shunt placement for the treatment of idiopathic intracranial hypertension
- PMID: 25449938
- PMCID: PMC4278113
- DOI: 10.4103/0301-4738.146012
Controversies: Optic nerve sheath fenestration versus shunt placement for the treatment of idiopathic intracranial hypertension
Abstract
Background: Idiopathic intracranial hypertension (IIH) has been increasing in prevalence in the past decade, following the obesity epidemic. When medical treatment fails, surgical treatment options must be considered. However, controversy remains as to which surgical procedure is the preferred surgical option - optic nerve sheath fenestration (ONSF) or cerebrospinal fluid (CSF) shunting - for the long-term treatment of this syndrome.
Purpose: To provide a clinical update of the pros and cons of ONSF versus shunt placement for the treatment of IIH.
Design: This was a retrospective review of the current literature in the English language indexed in PubMed.
Methods: The authors conducted a PubMed search using the following terms: Idiopathic IIH, pseudotumor cerebri, ONSF, CSF shunts, vetriculo-peritoneal shunting, and lumbo-peritoneal shunting. The authors included pertinent and significant original articles, review articles, and case reports, which revealed the new aspects and updates in these topics.
Results: The treatment of IIH remains controversial and lacks randomized controlled clinical trial data. Treatment of IIH rests with the determination of the severity of IIH-related visual loss and headache.
Conclusion: The decision for ONSF versus shunting is somewhat institution and surgeon dependent. ONSF is preferred for patients with visual symptoms whereas shunting is reserved for patients with headache. There are positive and negative aspects of both procedures, and a prospective, randomized, controlled trial is needed (currently underway). This article will hopefully be helpful in allowing the reader to make a more informed decision until that time.
Conflict of interest statement
Similar articles
-
A 15-year review of secondary and tertiary optic nerve sheath fenestration for idiopathic intracranial hypertension.Orbit. 2018 Aug;37(4):266-272. doi: 10.1080/01676830.2017.1423337. Epub 2018 Jan 9. Orbit. 2018. PMID: 29313398 Review.
-
Optic nerve sheath fenestration for idiopathic intracranial hypertension: a seven year review of visual outcomes in a tertiary centre.Clin Neurol Neurosurg. 2015 Oct;137:94-101. doi: 10.1016/j.clineuro.2015.05.020. Epub 2015 Jun 10. Clin Neurol Neurosurg. 2015. PMID: 26164677
-
Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration.J Neuroophthalmol. 2009 Dec;29(4):281-3. doi: 10.1097/WNO.0b013e3181c2530b. J Neuroophthalmol. 2009. PMID: 19952899
-
Idiopathic intracranial hypertension VISION (venous intervention versus shunting in IIH for optic nerve disc swelling) trial: patient perspective questionnaire.Br J Neurosurg. 2019 Feb;33(1):71-75. doi: 10.1080/02688697.2017.1374349. Epub 2017 Sep 21. Br J Neurosurg. 2019. PMID: 28934871
-
Complications of Optic Nerve Sheath Fenestration as a Treatment for Idiopathic Intracranial Hypertension.Semin Ophthalmol. 2018;33(1):36-41. doi: 10.1080/08820538.2017.1353810. Semin Ophthalmol. 2018. PMID: 29420144 Review.
Cited by
-
[Treatment of idiopathic intracranial hypertension by endovascular improvement of venous drainage of the brain].Ophthalmologe. 2015 Oct;112(10):821-7. doi: 10.1007/s00347-015-0136-1. Ophthalmologe. 2015. PMID: 26400795 Review. German.
-
Optic atrophy secondary to minocycline-induced idiopathic intracranial hypertension.BMJ Case Rep. 2023 Mar 28;16(3):e252731. doi: 10.1136/bcr-2022-252731. BMJ Case Rep. 2023. PMID: 36977510 Free PMC article.
-
Optic Disc Edema and Elevated Intracranial Pressure (ICP): A Comprehensive Review of Papilledema.Cureus. 2022 May 11;14(5):e24915. doi: 10.7759/cureus.24915. eCollection 2022 May. Cureus. 2022. PMID: 35698673 Free PMC article. Review.
-
Papilledema in NF2-related Schwannomatosis without Ventriculomegaly and Overt Intracranial Hypertension: A Case Series and Literature Review.NMC Case Rep J. 2025 Jun 11;12:241-247. doi: 10.2176/jns-nmc.2025-0034. eCollection 2025. NMC Case Rep J. 2025. PMID: 40599309 Free PMC article.
-
The management of elevated intracranial pressure and sinus vein thrombosis associated with mastoiditis: the experience of eighteen patients.Childs Nerv Syst. 2022 Feb;38(2):421-428. doi: 10.1007/s00381-021-05402-6. Epub 2021 Oct 29. Childs Nerv Syst. 2022. PMID: 34713346
References
-
- Hamdallah IN, Shamseddeen HN, Getty JL, Smith W, Ali MR. Greater than expected prevalence of pseudotumor cerebri: A prospective study. Surg Obes Relat Dis. 2013;9:77–82. - PubMed
-
- Friesner D, Rosenman R, Lobb BM, Tanne E. Idiopathic intracranial hypertension in the USA: The role of obesity in establishing prevalence and healthcare costs. Obes Rev. 2011;12:e372–80. - PubMed
-
- Biousse V, Rucker JC, Vignal C, Crassard I, Katz BJ, Newman NJ. Anemia and papilledema. Am J Ophthalmol. 2003;135:437–46. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous